$0.00

Molecular Diagnostics Market

Name: Molecular Diagnostics Market
SKU: 1508
Availability: InStock

Category: Healthcare

Report Preview

Molecular Diagnostics Market By Product & Services (Reagents & Kits, Instruments, and Services & Software) By Test Type (Lab Tests and POC Tests) By Application (Infectious diseases, Oncology, Genetic testing, and Blood screening) By Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT)) By End User (Hospital & Clinics and Diagnostic Laboratories) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2031.

In 2021, the market for Molecular Diagnostics worldwide was worth $37 billion US dollars. AMR Group projects that the market will reach US$ 42 billion by 2031, growing at a CAGR of 1.5 percent between 2022 and 2031.

Attribute	Key Insights
Estimated Market Value (2021)	37 USD Billion
Forecasted Market Value (2028)	42 USD Billion
CAGR % 2023-2028	2.0%`
Leading Region	North America

Market Dynamics

The molecular diagnostics market tends to grow due to the increasing prevalence of COVID-19 patients. An increase in infectious disease & cancer prevalence are the most significant factors driving this market’s growth. The rising demand for point-of-care testing along with the increased demand for high-priced specialist therapies & safer drugs are also expected to enhance the market growth. However, the increasing patient awareness about faster diagnostics along with growing adoption of analyzer software for molecular diagnostics allows cushions to the growth of market.

From past couple of years, different technological developments are being launched with new products of high efficient technology to offer the best possible treatment on time, these factors are estimated to generate profitable opportunities for the market.

COVID Impact

The COVID-19 pandemic has highly increased workflows in the diagnostic sector globally. The COVID-19 outbreak is preceded to have a positive impact on the growth of the global molecular diagnostics market. The COVID-19 pandemic has stressed the healthcare systems and increased the need for the development of diagnostic instruments & diagnostic service centers. Increase in number of COVID-19 cases raised the demand for RT-PCR (Real time polymerase chain reaction) tests to detect COVID-19. In 2020, the U.S. Food and Drug Administration (FDA) authorized an antigen test that was the first OTC (Over the counter product) completely for home diagnosis, used for detection of COVID-19. However, in 2020, a total of around 646 government laboratories & 247 private laboratories reported to Indian Council of Medical Research (ICMR) for COVID-19 testing. Also, there was an increase in adoption of immunoassays & molecular assays diagnostics tests for COVID-19. Along with major player in market increased their R&D activities to curb the COVID-19 pandemic are expected to positively impact the molecular diagnostics market growth.

Regional Trend

Geographically, the global tissue diagnostics market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Globally, North America dominates the molecular diagnostics market because of the increasing healthcare expenditure per capita and high demand for better healthcare facilities within the region.

In Asia-Pacific there is a significant growth expected during the forecast period of 2022 to 2029 due to the increased geriatric population, and increasing prevalence of cancer coupled with infectious disease in countries in Asia such as India & China. The development of healthcare infrastructure within the region is also increased. In 2020, the World Health Organization (WHO), the Africa Centers for Disease Control & Prevention, the global fund, the foundation for innovative new diagnostics, and the Bill & Melinda Gates foundation announced their partnership to provide around 120 million quality COVID-19 rapid tests affordable for low and middle income countries. This made a significant contribution toward the growth of the global molecular diagnostics market.

Competitive Landscape

Key players operating in the global tissue diagnostics market are Abbott Laboratories, Agilent Technologies Inc., Amoy Diagnostics Co., Ltd., BD, Biocartis, bioMérieux, Danaher, DiaSorin S.p.A, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., geneOmbio, Genetic Signatures, GenMark Diagnostics Inc., Grifols S.A., Hologic, Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Luminex Corporation, MDxHealth, Inc., Molbio Diagnostics Pvt. Ltd., Myriad Genetics Inc., QIAGEN, Quidel Corporation, Siemens, TBG Diagnostics Limited, Thermo Fisher Scientific, and Vela Diagnostics among others. In 2020, Roche Diagnostics India had launched the “Cobas 8800 instrument” at the National Institute of Cholera & Enteric Diseases, Kolkata, and “Cobas 6800”, coupled with SARS CoV-2 diagnostic testing. The Roche Cobas 6800/8800 systems deliver test findings in three and a half hours and enable greater operational efficiency, flexibility, and the fastest time for results.

Key USP’s-

According to WHO, in January 2021, the British in Vitro Diagnostics Association has made efforts by calling out NHS England for the development of a commissioning framework for molecular diagnostics in oncology.

Market Segmentation

Based upon the Product & Services used in molecular diagnostics market is segmented into three segments of Reagents & Kits, Instruments and Services & Software in the detection process. Further it is categorized according to its process and utilization. Based on the Test Type, the molecular diagnostics market is segmented into Lab Tests and POC Tests. Based on application, the molecular diagnostics market is segmented into Infectious diseases, Oncology, Genetic testing, and Blood screening. Based on Technology, the molecular diagnostics market is segmented into Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, and Isothermal Nucleic Acid Amplification Technology (INAAT). In this segment, the polymerase chain reaction (PCR) segment dominated the market as the largest revenue share in 2021. This is caused due to its use in the detection of COVID-19 & other infectious diseases. The increased use of high PCR kits to detect infectious diseases and genetic diseases is expected to drive market growth.

End user segment of tissue detection market is further classified into Hospitals & Clinics and Diagnostic Laboratories. Diagnostic labs segment dominated the market in terms of revenue owing to more inclination of patients towards the tests due to the rising prevalence of COVID-19 and other infections globally.

By Product & Services

Reagents & Kits
Instruments
Services & Software

By Test Type

Lab Tests
POC Tests

By Application

Infectious diseases
Oncology
Genetic testing
Blood screening

By Technology

Polymerase Chain Reaction (PCR)
Hybridization
DNA sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)

By End User

Hospital & Clinics
Diagnostic Laboratories

Global Molecular Diagnostics System Introduction and Market Overview
- Objectives of the Study
- Global Molecular Diagnostics System Scope and Market Estimation
  - Global Molecular Diagnostics System Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 – 2032)
  - Global Molecular Diagnostics System Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 – 2032
- Market Segmentation
  - Test Type of Global Molecular Diagnostics System
  - Product of Global Molecular Diagnostics System
  - Application of Global Molecular Diagnostics System
  - Technology of Global Molecular Diagnostics System
  - End User of Global Molecular Diagnostics System
  - Region of Global Molecular Diagnostics System

Executive Summary
Market Factor Analysis
- Global Molecular Diagnostics System Industry Trends under COVID-19 Outbreak
  - Global COVID-19 Status Overview
  - Influence of COVID-19 Outbreak on Global Molecular Diagnostics System Industry Development
- Market Dynamics, By Region
  - Drivers
  - Limitations
  - Opportunities
  - Impact Analysis of Drivers and Restraints
- Ecosystem / Value Chain Analysis
  - Raw Materials / Components Suppliers
  - Manufacturers / Vendors
  - Distributors
  - Buyers / End-users
  - Forward Integration & Backward Integration of Key Stakeholders
- Global Molecular Diagnostics System – Pricing Trends Analysis & Average Selling Prices (ASPs)
- End-User / Customer Preferences & Consumer Surveys
- Technology Roadmap & Key Innovations /Developments
- Key Mandates & Regulatory Scenario Analysis
- Patents Landscape
- Manufacturing Cost Structure Share Analysis
- Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.
- Porter’s Five Forces Analysis
  - Bargaining Power of Suppliers
  - Bargaining Power of Buyers
  - Threat of Substitutes
  - Threat of New Entrants
  - Competitive Rivalry
- PEST Analysis
  - Political Factors
  - Economic Factors
  - Social Factors
  - Technological Factors
- SWOT Analysis
- Russia-Ukraine War Impacts Analysis
- ANSOFF Matrix
  - Market Penetration Strategy
  - Product Development Strategy
  - Market Development Strategy
  - Diversification Strategy
- Inflation Impacts Analysis
  - Supply Side Impacts
  - Demand Side Impacts
  - Outlook in 2023 & Beyond
- Market Investment Feasibility Analysis
- Opportunity Map Analysis
- Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Regions
Global Molecular Diagnostics System Estimates & Historical Trend Analysis (2019 – 2022)
Global Molecular Diagnostics System Estimates & Forecast Trend Analysis, by Test Type
- Global Molecular Diagnostics System Revenue (US$ Mn) Estimates and Forecasts, by Test Type, 2019 to 2032
  - Lab Tests
  - POC Tests

Global Molecular Diagnostics System Estimates & Forecast Trend Analysis, by Product and Services
- Global Molecular Diagnostics System Revenue (US$ Mn) Estimates and Forecasts, by Product and Services, 2019 to 2032
  - Reagents & Kits
  - Instruments
  - Services & Software

Global Molecular Diagnostics System Estimates & Forecast Trend Analysis, by Technology
- Global Molecular Diagnostics System Revenue (US$ Mn) Estimates and Forecasts, by Technology, 2019 to 2032
  - Polymerase Chain Reaction (PCR)
  - Hybridization
  - DNA sequencing
  - Microarray
  - Isothermal Nucleic Acid Amplification Technology (INAAT)

Global Molecular Diagnostics System Estimates & Forecast Trend Analysis, by Application
- Global Molecular Diagnostics System Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2032
  - Infectious diseases
  - Oncology
  - Genetic testing
  - Blood screening

Global Molecular Diagnostics System Estimates & Forecast Trend Analysis, by End User
- Global Molecular Diagnostics System Revenue (US$ Mn) Estimates and Forecasts, by End User, 2019 to 2032
  - Hospital & Clinics
  - Diagnostic Laboratories

Global Molecular Diagnostics System Estimates & Forecast Trend Analysis, by Region
- Global Antibody-Drug Conjugates Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2032
  - North America
  - Europe
  - Asia Pacific
  - Middle East & Africa
  - South America

North America Molecular Diagnostics System: Estimates & Forecast Trend Analysis
- North America Antibody-Drug Conjugates Market Assessments & Key Findings
  - Molecular Diagnostics System Introduction
  - Molecular Diagnostics System Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Test Type
    - By Product and Services
    - By Application
    - By Technology
    - By End User
    - By Country
      - The U.S.
      - Canada
      - Mexico

Europe Molecular Diagnostics System: Estimates & Forecast Trend Analysis
- Europe Molecular Diagnostics System Assessments & Key Findings
  - Molecular Diagnostics System Introduction
  - Molecular Diagnostics System Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Test Type
    - By Product and Services
    - By Application
    - By Technology
    - By End User
    - By Country
      - Germany
      - K.
      - France
      - Italy
      - Spain
      - Russia
      - Rest of Europe

Asia Pacific Molecular Diagnostics System: Estimates & Forecast Trend Analysis
- Asia Pacific Market Assessments & Key Findings
  - Molecular Diagnostics System Introduction
  - Molecular Diagnostics System Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Test Type
    - By Product and Services
    - By Application
    - By Technology
    - By End User
    - By Country
      - China
      - Japan
      - India
      - Australia
      - South Korea
      - ASEAN
      - Rest of Asia Pacific

Middle East & Africa Molecular Diagnostics System: Estimates & Forecast Trend Analysis
- Middle East & Africa Market Assessments & Key Findings
  - Molecular Diagnostics System Introduction
  - Molecular Diagnostics System Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Test Type
    - By Product and Services
    - By Application
    - By Technology
    - By End User
    - By Country
      - A.E.
      - Saudi Arabia
      - Egypt
      - South Africa
      - Rest of Middle East & Africa

South America Molecular Diagnostics System: Estimates & Forecast Trend Analysis
- South America Market Assessments & Key Findings
  - Molecular Diagnostics System Introduction
  - Molecular Diagnostics System Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Test Type
    - By Product and Services
    - By Application
    - By Technology
    - By End User
    - By Country
      - Brazil
      - Argentina
      - Colombia
      - Rest of South America

Competition Landscape
- Molecular Diagnostics System Competition Index, By Leading Players
- Molecular Diagnostics System Competition White Space Analysis, By Application / End-user
- Molecular Diagnostics System Competition Heat Map Analysis, By Products / Services / Solutions
- Molecular Diagnostics System Competition Regional Intensity Map Analysis, By Geographies Served
- Molecular Diagnostics System Concentration & Company Market Shares (%) Analysis, 2022
- Molecular Diagnostics System Competition Quadrant Analysis, By Leading Players / Innovators / Emerging Players / New Entrants
Company Profiles
- BD
  - Company Overview & Key Stats
  - Financial Performance & KPIs
  - Product / Service / Solutions Portfolio & Applications / End-uses
  - Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below

bioMérieux SA
Bio-Rad Laboratories, Inc.
Abbott
Agilent Technologies, Inc.
Danaher
Hologic Inc. (Gen Probe)
Illumina, Inc.
Johnson & Johnson Services, Inc.
Grifols, S.A.
QIAGEN
Hoffmann-La Roche, Ltd.
Siemens Healthineers AG
Sysmex Corporation
Others

Research Methodology
- External Sources / Databases
- Internal Proprietary Database
- Primary Research
- Secondary Research
- Assumptions
- Limitations
- Report FAQs
Research Findings & Conclusion

Quick Contact

+13217109863

info@markettreeresearch.com

Molecular Diagnostics Market

Report Preview

ToC

Related products

Artificial Pancreas Device Systems Market

Plasma Fractionation Market

Artificial Pancreas Device Systems Market

Enzymes Market